Registry for patients treated with ion beam radiation therapy
A Prospective Registry Study to Record Clinical Results and Side Effects of Ion Beam Therapy at MedAustron
EBG MedAustron GmbH · NCT03049072
This study is collecting information from patients getting ion beam radiation therapy to see how well it works and how it affects their health and quality of life over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2800 (estimated) |
| Sex | All |
| Sponsor | EBG MedAustron GmbH (industry) |
| Drugs / interventions | radiation |
| Locations | 1 site (Wiener Neustadt, Lower Austria) |
| Trial ID | NCT03049072 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect standardized data from patients undergoing ion beam radiation therapy at MedAustron. It will track tumor control, treatment responses, and both acute and late toxicities over a period of up to 10 years. Additionally, the study will assess quality of life, sociodemographic factors, and perform neurocognitive evaluations for patients receiving brain radiation. The goal is to gather comprehensive information to improve future treatment protocols.
Who should consider this trial
Good fit: Ideal candidates are patients with tumor diseases who are being treated with ion beam therapy at MedAustron.
Not a fit: Patients with comorbidities that could jeopardize treatment delivery or compliance may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of ion therapy's effectiveness and safety, leading to improved patient outcomes.
How similar studies have performed: While this study focuses on a specific treatment modality, similar observational studies have shown success in improving treatment protocols and patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with tumor disease treated with ion beam therapy at MedAustron * Signed informed consent form Exclusion Criteria: * Comorbidities endangering treatment delivery or study compliance
Where this trial is running
Wiener Neustadt, Lower Austria
- EBG MedAustron GmbH — Wiener Neustadt, Lower Austria, Austria (RECRUITING)
Study contacts
- Principal investigator: Yvonne Goy, MD — EBG MedAustron GmbH
- Study coordinator: Yvonne Goy, MD
- Email: yvonne.goy@medaustron.at
- Phone: +43 2622 26 100
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Ion Beam Radiation Therapy for Tumor Patients